Document is current
Any future updates will be listed below
-
Authors
Zeymer, Uwe
Toelg, Ralph
Wienbergen, Harm
Hobbach, Hans-Peter
Cuneo, Alessandro
Bekeredjian, Raffi
Ritter, Oliver
Hailer, Birgit
Hertting, Klaus
Hennersdorf, Marcus
Scholtz, Werner
Lanzer, Peter
Mudra, Harald
Schwefer, Markus
Schwimmbeck, Peter-Lothar
Liebetrau, Christoph
Thiele, Holger
Claas, Christoph
Riemer, Thomas
Zahn, Ralf
-
Funding
Funding for this research was provided by:
Bayer
- License Information
-
More Information
Article History
Received: 28 August 2021
Revised: 6 December 2021
Accepted: 24 January 2022
First Online: 3 March 2022
Declarations
:
: U. Zeymer: speakers honoraria from Astra Zeneca, Bayer, BMS, Boehringer Ingelheim, Daicchi Sankyo, Pfizer, Sanofi; M. Hennersdorf: speakers honoraria from Astra Zeneca, Bayer, Berlin Chemie, Daiichi Sankyo. H. Wienbergen, H.-P. Hobbach, R. Toelg, A. Cuneo, R. Bekeredjian, O. Ritter, B. Hailer, K. Hertting, W. Scholtz, P. Lanzer, H. Mudra, M. Schwefer, P.‑L. Schwimmbeck, C. Liebetrau, H. Thiele, C. Claas, T. Riemer and R. Zahn declare that they have no competing interests.
: For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.
